Literature DB >> 15991012

Destructive operations in modern obstetrics.

Savita Rani Singhal1, Pooja Chaudhry, Krishna Sangwan, Suresh Kumar Singhal.   

Abstract

This is a retrospective study carried out over a period of 7 years at a tertiary care hospital to evaluate the indications, types and complications of destructive operations. During this period, 51 destructive operations were performed on women with obstructed labor and intrauterine fetal death. The most common operation performed was craniotomy (68.62%) followed by decapitation (19.60%), evisceration (7.84%) and cleidotomy (3.92%). The most common indication was cephalopelvic disproportion (31.25%). Out of 53 babies delivered (one triplet delivery), two were grossly malformed and 49.05% babies had birth weight between 3.0 kg and 4.0 kg and 9.43% were macrosomic. A total of 45.09% women had complications like atonic PPH, vaginal and perineal tears, puerperal sepsis and urinary tract infection. However, there was no maternal death. It is felt that for the women who belong to poor socio-economic status and have poor compliance and who present late in labor with features of obstruction, intrauterine sepsis and fetal death, destructive operation is still a good option.

Entities:  

Mesh:

Year:  2005        PMID: 15991012     DOI: 10.1007/s00404-005-0042-x

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  3 in total

Review 1.  Fetal surgery: a critical review.

Authors:  H Kitagawa; K C Pringle
Journal:  Pediatr Surg Int       Date:  2017-01-05       Impact factor: 1.827

2.  A foreign body in the cervix after spontaneous abortion: a rare case of a traumatic fetal decapitation.

Authors:  Danielle Holland; Johnathan Sheele
Journal:  Case Rep Emerg Med       Date:  2014-08-10

3.  Obstetric fistulae in southern Mozambique: incidence, obstetric characteristics and treatment.

Authors:  Sibone Mocumbi; Claudia Hanson; Ulf Högberg; Helena Boene; Peter von Dadelszen; Anna Bergström; Khátia Munguambe; Esperança Sevene
Journal:  Reprod Health       Date:  2017-11-10       Impact factor: 3.223

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.